An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
7th Army Training Command
7th ATC
Search 7th ATC:
Search
Search
Search 7th ATC:
Search
Home
About Us
Mission
Our History
Leadership
Staff
Chaplain
G1
G2
G3
G4
G6
G8
IG
MRA
Public Affairs
Protocol
SJA
SHARP
Directorates and Commands
Combined Arms Training Center
Grafenwoehr Training Area
International Special Training Centre
Joint Multinational Readiness Center
Joint Multinational Simulation Center
Noncommissioned Officer Academy
Training Support Activity Europe
Units
Joint Multinational Training Group-Ukraine
Georgian Defense Readiness Program-Training
HHC
Environment
Competitions
Europe Best Sniper Team
USAREUR-AF International Tank Challenge
USAREUR-AF Best Squad
European Best Medic Competition
Exercises
Allied Spirit
Combined Resolve
Saber Junction
Media & News
Uebungsbetrieb
Newcomers
A to Z
Contact Us
Home
:
Media & News
:
Video
DVIDSVideoPlayer
Playlist:
Search Results
Video by Sara Barger
Player Embed Code:
<iframe width='500' height='300' scrolling='no' frameborder='0' style='border: none; overflow: hidden; width: 500px; height: 300px;' allowtransparency='true' src='https://www.dvidshub.net/video/embed/893587'></iframe>
Download
Embed
Share
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (clean version)
Defense Health Agency
Aug. 14, 2023 | 3:49
The Broad-Spectrum Snakebite Antidote IPT and small-business partner, Ophirex Inc, accelerated the technical and programmatic maturity of the critical life-saving drug, varespladib, including two pivotal clinical trials in 4 years. The team mitigated manufacturing and clinical risks through early FDA engagement and capitalized on opportunities to accelerate schedule, utilizing SBIR contracting mechanisms; financial and acquisition planning; and stakeholder engagement. The team’s efforts will result in FDA-approval and fielding nearly 3 years ahead of schedule, providing an important capability for Warfighters deployed in far-forward, austere conditions where snakebites are a significant threat to life and limb.
This version of the video has no music or lowerthird graphics.
More
Tags
Ft. Detrick
MHSRS 2023
BSSA
Broad spectrum snakebite antidote
More
Up Next
Now Playing
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (clean version)
3:47
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (captioned)
3:47
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT
More Videos